Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.

Current Report (Form 8-K | Period ending 2024-11-19)

Current Report (Form 8-K | Period ending 2024-11-15)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Boston Scientific (BSX US)

Current Report (Form 8-K | Period ending 2024-11-19)

Current Report (Form 8-K | Period ending 2024-11-15)

Current Report (Form 8-K | Period ending 2024-11-07)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-10-23)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)